MetLife Investment Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

MetLife Investment Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,244	Closed	-$152K	–	2250
2017 Q4	$152K	Buy	+6,244	New	+$120K	﹤0.01%	2063

MetLife Investment Management's ENTL Position: Q1 2018 in Review

MetLife Investment Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 6,244 shares — an estimated $152K sold.

MetLife Investment Management first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $152K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

MetLife Investment Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
MetLife Investment Management sold 6,244 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $152K.
MetLife Investment Management first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
MetLife Investment Management's Entellus Medical, Inc. Common Stock position peaked at $152K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.